Helen Dennis is a nationally recognized leader on issues of aging and the new retirement with academic, corporate and ...

Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

A fresh look at Alzheimer’s disease has uncovered a hidden pathway from your gut to your brain—one that carries a potent ...

Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

In a preclinical study, Cedars-Sinai investigators found that boosting angiotensin-converting enzyme (ACE) in key immune ...

Antonella Zanobetti was conducting groundbreaking research to examine links between exposure to environmental factors, such ...

Two already-approved medications may help overturn brain changes caused by Alzheimer's disease, according to a recent study ...

New research reveals how breaking down stored glucose (glycogen) in the brain may reduce toxic protein buildup linked to ...

Four years of lecanemab treatment led to less cognitive decline and potentially even improvement in clinical scores over time, with a favorable safety profile, in the open-label extension trial.

A history of traumatic brain injury was linked to long-term cognitive decline involving speech functions, specifically where ...

A new study reveals that older men with Alzheimer's disease face nearly twice the risk of developing hospital-acquired pneumonia (HAP) compared to women with Alzheimer’s, suggesting that gender-based ...

Findings from a Phase III study highlight the demonstrated action of donanemab-azbt (brand name Kisunla) in slowing the ...